Association of neovascular age-related macular degeneration with specific gene expression patterns in peripheral white blood cells.
暂无分享,去创建一个
[1] I. Chowers,et al. Sequence variants in HTRA1 and LOC387715/ARMS2 and phenotype and response to photodynamic therapy in neovascular age-related macular degeneration in populations from Israel , 2008, Molecular vision.
[2] I. Chowers,et al. Association of complement factor H Y402H polymorphism with phenotype of neovascular age related macular degeneration in Israel , 2008, Molecular vision.
[3] G. Parmigiani,et al. Toll-like receptor 3 and geographic atrophy in age-related macular degeneration. , 2008, The New England journal of medicine.
[4] Martin Oppermann,et al. Systemic Complement Activation in Age-Related Macular Degeneration , 2008, PloS one.
[5] I. Chowers,et al. Lack of benefit of early awareness to age-related macular degeneration , 2008, Eye.
[6] P. Mitchell,et al. The LOC387715 polymorphism, inflammatory markers, smoking, and age-related macular degeneration. A population-based case-control study. , 2008, Ophthalmology.
[7] I. Simon,et al. Molecular characteristics of liver metastases from uveal melanoma. , 2007, Investigative ophthalmology & visual science.
[8] P. Debré,et al. CX3CR1-dependent subretinal microglia cell accumulation is associated with cardinal features of age-related macular degeneration. , 2007, The Journal of clinical investigation.
[9] Johanna M Seddon,et al. Variation in complement factor 3 is associated with risk of age-related macular degeneration , 2007, Nature Genetics.
[10] F. Ferris,et al. Age-related macular degeneration and the immune response: implications for therapy. , 2007, American journal of ophthalmology.
[11] I. Deary,et al. Complement C3 variant and the risk of age-related macular degeneration. , 2007, The New England journal of medicine.
[12] J. Kowalak,et al. Murine ccl2/cx3cr1 deficiency results in retinal lesions mimicking human age-related macular degeneration. , 2007, Investigative ophthalmology & visual science.
[13] P. Mitchell,et al. Circulating inflammatory markers and hemostatic factors in age-related maculopathy: a population-based case-control study. , 2007, Investigative ophthalmology & visual science.
[14] John D Lambris,et al. Complement and coagulation: strangers or partners in crime? , 2007, Trends in immunology.
[15] R. Apte,et al. Macrophages Inhibit Neovascularization in a Murine Model of Age-Related Macular Degeneration , 2006, PLoS medicine.
[16] J. Gregg,et al. Genomic profiles for human peripheral blood T cells, B cells, natural killer cells, monocytes, and polymorphonuclear cells: comparisons to ischemic stroke, migraine, and Tourette syndrome. , 2006, Genomics.
[17] Yibo Wang,et al. VKORC1 Haplotypes Are Associated With Arterial Vascular Diseases (Stroke, Coronary Heart Disease, and Aortic Dissection) , 2006, Circulation.
[18] R. T. Smith,et al. Variation in factor B (BF) and complement component 2 (C2) genes is associated with age-related macular degeneration , 2006, Nature Genetics.
[19] R. Scott,et al. Preliminary investigation of gene expression profiles in peripheral blood lymphocytes in schizophrenia , 2006, Schizophrenia Research.
[20] J. Frostegård,et al. Annexin A5 in cardiovascular disease and systemic lupus erythematosus. , 2005, Immunobiology.
[21] R V Jensen,et al. Genome-wide expression profiling of human blood reveals biomarkers for Huntington's disease. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[22] Santa Jeremy Ono,et al. Circulating anti‐retinal antibodies as immune markers in age‐related macular degeneration , 2005, Immunology.
[23] B. Rosner,et al. Progression of age-related macular degeneration: prospective assessment of C-reactive protein, interleukin 6, and other cardiovascular biomarkers. , 2005, Archives of ophthalmology.
[24] Yibo Wang,et al. Vitamin K Epoxide Reductase: A Protein Involved in Angiogenesis , 2005, Molecular Cancer Research.
[25] C. Osmond,et al. Association of HLA class I and class II polymorphisms with age-related macular degeneration. , 2005, Investigative ophthalmology & visual science.
[26] J. Gilbert,et al. Complement Factor H Variant Increases the Risk of Age-Related Macular Degeneration , 2005, Science.
[27] J. Ott,et al. Complement Factor H Polymorphism in Age-Related Macular Degeneration , 2005, Science.
[28] A. Edwards,et al. Complement Factor H Polymorphism and Age-Related Macular Degeneration , 2005, Science.
[29] E. Chew,et al. The involvement of sequence variation and expression of CX3CR1 in the pathogenesis of age‐related macular degeneration , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[30] George Stephanopoulos,et al. Microarray detection of E2F pathway activation and other targets in multiple sclerosis peripheral blood mononuclear cells , 2004, Journal of Neuroimmunology.
[31] N. Rifai,et al. Association between C-reactive protein and age-related macular degeneration. , 2004, JAMA.
[32] M. Miyagi,et al. Carboxyethylpyrrole Protein Adducts and Autoantibodies, Biomarkers for Age-related Macular Degeneration* , 2003, Journal of Biological Chemistry.
[33] Eiji Sakurai,et al. An animal model of age-related macular degeneration in senescent Ccl-2- or Ccr-2-deficient mice , 2003, Nature Medicine.
[34] A. Hackam,et al. Identification of novel genes preferentially expressed in the retina using a custom human retina cDNA microarray. , 2003, Investigative ophthalmology & visual science.
[35] K. Csaky,et al. Macrophage depletion diminishes lesion size and severity in experimental choroidal neovascularization. , 2003, Investigative ophthalmology & visual science.
[36] J. Ambati,et al. Macrophage depletion inhibits experimental choroidal neovascularization. , 2003, Investigative ophthalmology & visual science.
[37] Virginia Pascual,et al. Interferon and Granulopoiesis Signatures in Systemic Lupus Erythematosus Blood , 2003, The Journal of experimental medicine.
[38] A I Saeed,et al. TM4: a free, open-source system for microarray data management and analysis. , 2003, BioTechniques.
[39] Masaru Miyagi,et al. Drusen proteome analysis: An approach to the etiology of age-related macular degeneration , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[40] Robert F Mullins,et al. A role for local inflammation in the formation of drusen in the aging eye. , 2002, American journal of ophthalmology.
[41] M. Tytell,et al. Retinal uptake of intravitreally injected Hsc/Hsp70 and its effect on susceptibility to light damage. , 2001, Molecular vision.
[42] S. Bernstein,et al. Heat shock cognate-70 gene expression declines during normal aging of the primate retina. , 2000, Investigative ophthalmology & visual science.
[43] S. Russell,et al. Drusen associated with aging and age‐related macular degeneration contain proteins common to extracellular deposits associated with atherosclerosis, elastosis, amyloidosis, and dense deposit disease , 2000, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[44] L. V. Johnson,et al. A potential role for immune complex pathogenesis in drusen formation. , 2000, Experimental eye research.
[45] C. Reutelingsperger,et al. Annexin V, the regulator of phosphatidylserine-catalyzed inflammation and coagulation during apoptosis , 1997, Cellular and Molecular Life Sciences CMLS.
[46] M. Tso,et al. Antiretinal antibodies in serum of patients with age-related macular degeneration. , 1991, Ophthalmology.
[47] H. Sakaguchi,et al. Annexins in Bruch's membrane and drusen. , 2006, Advances in experimental medicine and biology.
[48] Gordon K. Smyth,et al. limma: Linear Models for Microarray Data , 2005 .
[49] P. Penfold,et al. Senile macular degeneration: The involvement of immunocompetent cells , 2005, Graefe's Archive for Clinical and Experimental Ophthalmology.
[50] J. Provis,et al. Autoantibodies to retinal astrocytes associated with age-related macular degeneration , 2004, Graefe's Archive for Clinical and Experimental Ophthalmology.
[51] Jennifer I. Lim,et al. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8. , 2001, Archives of ophthalmology.
[52] M. Killingsworth,et al. Macrophages related to Bruch's membrane in age-related macular degeneration , 1990, Eye.